SoundBite’s main technology, SoundBiteTM Crossing System, is a unique and novel first-in-class wire-based technology that may potentially allow the treatment of chronic total occlusions (CTOs) in a simpler and clinically efficient way. CTOs are problematic and prevalent in patients with coronary artery disease (CAD) and peripheral artery disease (PAD). Currently, there is no efficient product solution and crossing CTOs is still considered a significant unmet need, representing an addressable growing niche market greater than 300,000 cases per year in the USA, alone.
At present, SoundBite is conducting its First-In-Human study using the first generation console and the first generation 0.018 inch SoundBiteTM Active Wire for peripheral (i.e., above and below the knee) application. In parallel, SoundBite is developing a 0.014-inch diameter wire for coronary application.